Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

Modification of HDL structure and function in individuals with diabetes and the haptoglobin 2-2 genotype

(2009) Andrew P Levy   Clinical Lipidology

C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease

(2008) P. M Ridker   CLINICAL CHEMISTRY

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

(2008) J. Sierra-Johnson et al.   EUROPEAN HEART JOURNAL

Accuracy of a heart failure diagnosis in administrative registers

(2008) Thomas Kümler et al.   EUROPEAN JOURNAL OF HEART FAILURE

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS)

(2008) I. Holme et al.   JOURNAL OF INTERNAL MEDICINE

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS)

(2008) I. Holme et al.   JOURNAL OF INTERNAL MEDICINE

Haptoglobin, inflammation and disease

(2008) Isaac K. Quaye   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE